InnovoTEX Inc. — Form D
InnovoTEX Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2026-08-06. The offering totals $4.0M, of which $750K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2026-08-06
- Form: D
- Accession: 0001971887-26-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $750K
- Remaining: $3.3M
- Investors: 14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-593292
Issuer
- Name: InnovoTEX Inc.
- CIK: 0001971887
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 3800 NORTH LAMAR BLVD. SUITE 200, AUSTIN, TX, 78756
- Phone: 570-510-6372
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Jonathan Arambula | Related Person | Austin, TX |
| James Hussey | Related Person | Austin, TX |
| Krystle Karoscik | Related Person | Austin, TX |
| Jonathan Sessler | Related Person | Austin, TX |
| Jonathan Sessler | Director | Austin, TX |
| Krystle Karosik | Executive Officer | Austin, TX |
| Joseph Arambula | Director | Austin, TX |
| Joseph Arambula | Executive Officer | Austin, TX |
Other filings by this issuer (2)
More